Last reviewed · How we verify

NCT04443231

Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation

Completed Last updated 23 June 2020
What this trial tests

trial testing Optical Coherence Tomography Angiography in Adolescent in 25 participants. Completed in 1 October 2019.

Timeline
1 November 2018
Primary endpoint
1 October 2019
1 October 2019

Quick facts

Lead sponsorPeking University Third Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment25
Start date1 November 2018
Primary completion1 October 2019
Estimated completion1 October 2019
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Adults 18 to 45, any sex, with Adolescent or Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To observe the retinal microvascular alteration during 3 months follow-up after Implantable Collamer Lens (ICL) operation in moderate and high myopia patients using quantitative optical coherence tomography angiography (OCTA) analysis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Evaluation of biometric indicators of anterior segment parameters after ICL implantation by swept-source optical coherence tomography.
    Tang C, Sun T, Sun Z, Duan H, et al · · 2023 · cited 7× · PMID 37131213 · DOI 10.1186/s12886-023-02942-0
  2. Prospective clinical study of retinal microvascular alteration after ICL implantation.
    Tang C, Zhang Y, Sun T, Xie J, et al · · 2023 · cited 1× · PMID 36743408 · DOI 10.3389/fcell.2023.1115822

Verify or expand the search:

Other trials of Optical Coherence Tomography Angiography

Trials testing the same drug.

Other recruiting trials for Adolescent

Currently open trials in the same condition.

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04443231.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing